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influence association with RNA-binding 
proteins that alter gene expression (Fig-
ure 1C; Kedde et al., 2007).
The reported link between the use of 
shorter 3′UTR isoforms, avoidance of 
regulation by miRNAs, and enhanced 
cellular proliferation is consistent with 
several previous observations. Global 
downregulation of miRNA expression is 
common in cancer (Lu et al., 2005) and 
promotes cellular transformation and 
tumorigenesis (Kumar et al., 2007); miR-
NAs influence many aspects of cellular 
proliferation and cell-cycle progression 
(reviewed in Carleton et al., 2007). More-
over, many genes have been evolution-
arily selected for enrichment or depletion 
of miRNA binding sites through changes 
in the lengths of their 3′UTRs, and the 
avoidance of miRNA target sites is cor-
related with spatial and temporal coex-
pression of mRNAs and miRNAs (Stark 
et al., 2005).
The work by Sandberg et al. points to 
a dynamic interplay between alternative 
polyadenylation of mRNAs and regula-
tion by miRNAs. The coexpression of 
genes with miRNAs that target them 
might be required in specific cell types 
in certain circumstances. Shifting gene 
expression to shorter 3′UTR isoforms, 
which are devoid of target sequences for 
the specific miRNAs, is a mechanism to 
avoid an undesirable decrease in protein 
expression (Figure 1B). It is also conceiv-
able that specific RNA-binding proteins 
are involved in this process (Figure 1C). 
Future experiments should determine 
the molecular mechanisms governing 
this global switch in PAS usage.
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Mitotic exit in budding yeast is regulated by the proteins Cdc14, APC/CCdh1, and Plk1. In this issue, 
Bassermann and colleagues (2008) show that this network of proteins has been rewired in human 
cells to control the cell cycle in response to DNA damage.Molecular networks often adapt to per-
form different tasks in different organ-
isms. For example, the small GTP-
binding Ras proteins that are implicated 
in nutrient uptake in the budding yeast 
Saccharomyces cerevisiae have evolved 
into central regulators of growth and 
proliferation in metazoans. In this issue 
of Cell, Bassermann and coworkers 
describe a similarly striking example of 
“molecular bricolage,” a clever adapta-
tion of materials at hand for a new pur-
pose. The authors show that the con-
served regulatory network consisting 
of the phosphatase Cdc14, the ubiquitin 
ligase anaphase-promoting complex or 
cyclosome (APC/C), and the Polo-like 
kinase 1 (Plk1)—long implicated in con-
trolling mitotic exit in budding yeast—is 
repurposed in human cells to mediate 
the DNA-damage-induced G2 cell-cycle 
block.
The goal of cell division is to generate 
two daughter cells genetically identical 
to the mother cell. To minimize genetic 
instability, eukaryotes have developed 
surveillance mechanisms called check-
points (Figure 1) consisting of highly 
conserved signal transduction pathways 
that monitor cell-cycle progression and 
delay the process when key events go 
wrong to allow for error correction. The 
G2 checkpoint is an important com-
ponent of the DNA-damage response, 
which delays entry into mitosis in the 
presence of DNA lesions. During the 
G2 block, numerous proteins including 
the ATR kinase collaborate to activate 
the kinase Chk1, which maintains a cell-
cycle arrest through inhibition of mitotic 
cyclin-dependent kinase (Cdk1) activity. 
Chk1 inactivates the Cdc25 protein to 
ensure that Cdk1 remains in an inactive 
state (Figure 1). Cell-cycle reentry fol-
lowing DNA repair is mediated by Plk1, 
whose kinase activity triggers the deg-
radation of a series of targets, including 
Claspin, an adaptor protein required by 210 Cell 134, July 25, 2008 ©2008 Elsevier Inc.
ATR to maintain Chk1 activity (Branzei 
and Foiani, 2008; Harper and Elledge, 
2007). Although many of the proteins 
mediating the G2 cell-cycle block and 
recovery from it are known, numerous 
open questions remain. For example, 
how is Plk1 activity restrained during the 
G2 cell-cycle block?
Bassermann and colleagues set out to 
elucidate this question and implicated the 
APC/C ubiquitin ligase complex in Plk1 
figure 1. The cell cycle and G2 DnA- 
Damage Response in Human cells
DNA damage during the cell cycle triggers the 
DNA-damage checkpoint and results in a block 
of the cell cycle (right) at G2 via the inhibition of 
mitotic cyclin-dependent kinase (Cdk1) activ-
ity. Bassermann et al. (2008) find a new regula-
tory pathway of the G2 DNA-damage checkpoint 
(shaded box) in which the phosphatase Cdc14B 
activates the ubiquitin ligase anaphase-promoting 
complex or cyclosome (APC/CCdh1) to degrade the 
Polo-like kinase 1 (Plk1) and arrest the cell cycle. 
Plk1 is required for cell-cycle reentry as its kinase 
activity triggers inactivation (by the ubiquitin ligase 
SCFβTrCP) of Cdk1 inhibitors such as Wee1 and 
Claspin, an adaptor protein required by the kinase 
ATR to maintain Chk1 inhibition of Cdc25, an ac-
tivator of Cdk1. During the G2 cell-cycle arrest, 
APC/CCdh1 specifically degrades only Plk1 and not 
other substrates such as Claspin due to the ac-
tion of the deubiquitinating enzyme Usp28. Upon 
DNA repair, Cdk1 is reactivated to allow cell-cycle 
progression from G2 to mitosis.degradation during the DNA-damage 
response in cultured human cells (Fig-
ure 1, shaded box). The APC/C, a central 
regulator of the cell cycle, is a multisub-
unit ubiquitin ligase thought to primar-
ily function during mitosis and in G1. Its 
activity depends on two distinct activa-
tor proteins named Cdc20 and Cdh1 (the 
resulting complexes with the APC/C are 
indicated as APC/CCdc20 and APC/CCdh1, 
respectively). Whereas Cdc20 mediates 
entry into anaphase, Cdh1 mediates 
events that are important for mitotic exit 
and maintenance of the G1 state. APC/
CCdh1 activity is suppressed during the 
G2 phase of the cell cycle. However, the 
APC/CCdh1 is transiently activated in G2 
upon DNA damage (Sudo et al., 2001). 
Bassermann et al. now connect this 
transient activation of the APC/CCdh1 to 
the regulation of Plk1. Out of 15 known 
APC/CCdh1 substrates, the authors found 
that only Plk1 was degraded while oth-
ers such as Claspin appeared to be pro-
tected from degradation despite being 
ubiquitinated. Indeed, DNA-damaged 
cells expressing a mutant form of Plk1 
not recognized by the APC/CCdh1 (and 
thus not degraded) showed a greater ten-
dency to escape from the DNA-damage 
checkpoint and enter mitosis. Intrigu-
ingly, though Cdh1 is a not an essential 
gene for mouse embryonic and somatic 
cells, mouse embryonic fibroblasts lack-
ing Cdh1 showed increased genomic 
instability, a possible consequence of a 
faulty DNA-damage checkpoint (Garci-
Higuera et al., 2008).
If APC/CCdh1 activity is normally sup-
pressed in G2, how is it reactivated to 
downregulate Plk1 protein levels upon 
DNA damage in human cells? Previ-
ous studies have shown that in order to 
interact with the APC/C, the Cdk-medi-
ated phosphorylation of Cdh1 must be 
reversed. In budding yeast, this dephos-
phorylation is mediated by the conserved 
phosphatase Cdc14, a protein crucial for 
exit from mitosis (Stegmeier and Amon, 
2004). Cdc14 activity in budding yeast is 
modulated spatially: Cdc14 is kept inac-
tive inside the nucleolus by its inhibi-
tor Cfi1/Net1 until metaphase. During 
early anaphase, Cdc14 is released into 
the nucleus. In mid-to-late anaphase, it 
also moves into the cytoplasm to reach 
its myriad substrates, including Cdh1 
(Stegmeier and Amon, 2004). In humans, Cellthe two orthologs of Cdc14 (Cdc14A and 
Cdc14B) localize dynamically during the 
cell cycle. Cdc14A localizes to interphase 
centrosomes and regulates centrosome 
separation, whereas Cdc14B localizes 
to interphase nucleoli similarly to bud-
ding yeast Cdc14. During mitosis, both 
isoforms disperse throughout the cell 
(Krasinska et al., 2007), but the details 
of their activity following their release 
remain poorly understood.
Guided by previous studies in bud-
ding yeast, Bassermann and colleagues 
examined if Cdc14A and Cdc14B change 
localization upon DNA damage. The 
authors found that following the activa-
tion of the DNA-damage response, only 
Cdc14B relocalized from the nucleolus 
into the nucleus. Furthermore, Cdc14B 
bound to Cdh1 and triggered APC/
CCdh1 activity in a manner similar to that 
observed in budding yeast. Consistent 
with a role in regulating Plk1 levels via 
regulation of Cdh1, silencing Cdc14B led 
to a stabilization of the Plk1 protein similar 
to that observed when Cdh1 is silenced. 
Though the role of Cdc14 in mitotic exit is 
well established in budding yeast, clues 
to its function in higher eukaryotes have 
been scanty until now. This exciting dem-
onstration of association between Cdc14 
activity and the DNA-damage response 
opens the door to many new questions. 
For example, does an analogous G2 reg-
ulatory pathway exist in budding yeast or 
is this newly discovered activity of Cdc14 
and its targets a reflection of nature’s 
creative use of a conserved pathway to 
provide solutions for a specific need?
This regulatory network uncovered by 
Bassermann et al. also opens up new 
areas of inquiry. One question concerns 
the mechanism by which the APC/CCdh1 
is activated. Previous analyses have 
demonstrated that the APC/CCdh1 is kept 
inactive during G2 not only via phospho-
rylation but also by its inhibitor Emi1 (Di 
Fiore and Pines, 2008). But how does 
Emi integrate into this role of APC/CCdh1 
during the DNA-damage response? Is its 
inactivation required for Plk1 degrada-
tion? It will be important in future experi-
ments to examine the fate of Emi1 dur-
ing the DNA-damage response. Another 
question pertains to how and via what 
signals Cdc14B becomes released from 
the nucleolus upon DNA damage. In bud-
ding yeast, the release of Cdc14 occurs  134, July 25, 2008 ©2008 Elsevier Inc. 211
through the sequential action of two reg-
ulatory networks, the FEAR (Cdcfourteen 
early anaphase release) network and the 
MEN (mitotic exit network) (Stegmeier 
and Amon, 2004). Although the com-
ponents of both pathways are not fully 
conserved in humans, the initiation and 
maintenance of released Cdc14 in bud-
ding yeast depend on the Plk1 homolog 
Cdc5. By activating APC/CCdh1, which in 
turn promotes the degradation of Cdc5, 
Cdc14 triggers its own inactivation (Vis-
intin et al., 2008). It is possible that a sim-
ilar mechanism underlies the Cdc14B-
mediated DNA-damage response. If 
Plk1 proves to be important for the 
release of Cdc14B in the DNA-damage 
response, then the same circuitry could 
govern both the entry and exit from the 
G2 cell-cycle block as Cdc14 inactiva-212 Cell 134, July 25, 2008 ©2008 Elsevier 
The discovery that the transcriptional 
activator CLOCK functions as a his-
tone acetyltransferase (HAT) (Doi et al., 
2006) has implicated chromatin remod-
eling in the circadian regulation of gene 
expression. In this sense, the existence 
of a histone deacetylase (HDAC) that 
counteracts the HAT activity of CLOCK 
could perhaps have been anticipated. 
However, not all deacetylases achieve 
their goal in the same way, and this is in 
part why the work by Asher et al. (2008) 
and Nakahata et al. (2008) presented in 
this issue is of such compelling interest. 
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The transcriptional activator CLO
expression of many genes. Ashe
NAD+-dependent enzyme SIRT1
of CLOCK. These results broade
circadian system.tion could then allow for the accumula-
tion of Plk to promote cell-cycle reentry. 
The work by Bassermann et al. suggests 
broader roles for both Cdc14 and APC/
CCdh1 in the regulation of the cell cycle, 
thus shedding light on an interesting new 
pathway in the cellular response to DNA 
damage.
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tin, R. (2008). Genes Dev. 22, 79–90.protein with its extensive connections, 
both to aging and energy metabolism, 
into the circadian fold.
Analysis of the molecular basis of the 
circadian rhythm in the fruit fly Droso-
phila, the fungus Neurospora, mice, and 
human cells in culture has revealed at its 
core a common architecture, a transcrip-
tion-translation feedback loop in which a 
heterodimeric transcription factor, whose 
parts interact via PAS domains, drives the 
expression of proteins that turn down the 
activity of their heterodimeric activator. In 
mammalian cells, the transcriptional acti-
se for core 
that is required for the circadian 
2008) now demonstrate that the 
se that counteracts the activity 
t of cellular metabolism on the 
